SenesTech, Inc. (SNES) stock surged to 6.08% in the aftermarket – what’s happening?

SenesTech, Inc. (SNES) showed an incline of 6.08% in the aftermarket. However, the last trading session concluded at $1.48 with an increase of 1.37%.

Top 5 Tech Stocks to Buy in 2024

Don't let the chaos of rising interest rates, potential recession, tighter credit issues, higher oil prices, and incessant geopolitical issues chase you from the markets. Instead, just wait it out. With too much fear in the market, go bargain hunting with tech stocks. We have complied a report with the five of the best ways to profit within this industry. "Top 5 AI Stocks to Buy in 2024."

Click here to sign up for our free report & newsletter, plus bonus offer "Elon Musk just Tiggered a BOOM in These Stocks"


Control of Soaring Rat Populations

On 26th October 2021, SNES announced that Municipalities around the United States are employing SenesTech’s rat contraceptive, ContraPest. This is done to curb skyrocketing rat populations only one year after the rodent fertility control specialists transformed from a science-based research firm to a commercial one. Newton, Massachusetts has now joined the list of communities that have successfully included ContraPest into their pest control programs, including Hartford, San Francisco, and Washington, D.C.

It is the only EPA-approved rat contraception, and it is a non-toxic, non-lethal, long-term method to manage rat populations that has become much worse in cities as a result of the epidemic. Lastly, ContraPest has shown extraordinary effectiveness in lowering rat populations, frequently by more than 94 percent, while remaining ecologically friendly and long-term.

Second Quarter 2021 Results

SNES announced second-quarter 2021 results on 12th August 2021. More than 250 new clients were recruited during the second quarter, bringing the total number of active consumers to approximately 500. Importantly, the average order value is increasing, and turnover is decreasing. Moreover, enhanced marketing, branding, and media relations efforts, a new website, and branding, strategic cooperative relationships are just a few of the sales acceleration tactics used by ContraPest.

SNES had success second quarter in 2021, with record quarterly revenue that was more than twice that of the previous quarter and up 82 percent from the previous quarter. Furthermore, SNES is employing comprehensive real-world data that proves how ContraPest drastically decreases rat populations to drive demand in high-value, focused market sectors, while increasing engagement.

First Quarter 2021 Results

SNES reported first-quarter 2021 results on 13th May 2021. Revenues during the first quarter of 2021 were up 138 percent year over year, while operational expenditures were down 20%. SNES has evolved over the last year from a science-based research firm to a solutions-based, environmentally-conscious commercial company. The company offers a new and proven instrument for pest control management in the twenty-first century. Furthermore, during the first quarter of this year, the state of California provided over a third of SenesTech’s income. In January 2021, California passed laws limiting the use of four main second-generation anticoagulation rat poisons, paving the way for non-lethal, effective pest management alternatives. SNES has also created relationships and cooperation with important distributors who are now offering ContraPest fertility management as part of their pest management programs. Last but not least, SNES recently completed the first purchase with a major East Coast city, and agencies are requesting that ContraPest be included in their IPM programs.